Alzamend Neuro : Failure to Satisfy Listing Rule : vimarsana

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


____________________________________________________________


...

Related Keywords

Washington , United States , Delaware , Henry Nisser , Hearings Panel The , Securities Exchange , Exchange Commission , Nasdaq , Commission File Number , Nasdaq Stock Market , Alzamend Neuro Inc , Securities Exchange Act , Second Floor , Zip Code , Securities Act , Exchange Act , Continued Listing Rule , Alzamend Neuro , Listing Qualifications Staff , Listing Rule , Nasdaq Capital Market , Hearings Panel , Nasdaq Listing Rule , Regulations T , Xtensible Business Reporting Language , Page Interactive Data File , Vice President , General Counsel , Markets ,